Upgrades
- For Copa Holdings SA CPA, UBS upgraded the previous rating of Neutral to Buy. In the second quarter, Copa Holdings showed an EPS of $0.32, compared to $0.38 from the year-ago quarter. At the moment, the stock has a 52-week-high of $97.63 and a 52-week-low of $55.25. Copa Holdings closed at $72.94 at the end of the last trading period.
- According to UBS, the prior rating for Medpace Holdings Inc MEDP was changed from Sell to Neutral. Medpace Hldgs earned $2.05 in the third quarter, compared to $1.29 in the year-ago quarter. The current stock performance of Medpace Hldgs shows a 52-week-high of $235.72 and a 52-week-low of $126.94. Moreover, at the end of the last trading period, the closing price was at $221.50.
- For Teradyne Inc TER, Craig-Hallum upgraded the previous rating of Hold to Buy. For the third quarter, Teradyne had an EPS of $1.15, compared to year-ago quarter EPS of $1.59. At the moment, the stock has a 52-week-high of $167.69 and a 52-week-low of $67.81. Teradyne closed at $82.25 at the end of the last trading period.
- HSBC upgraded the previous rating for Ferrari NV RACE from Hold to Buy. For the second quarter, Ferrari had an EPS of $1.45, compared to year-ago quarter EPS of $1.34. At the moment, the stock has a 52-week-high of $271.95 and a 52-week-low of $167.45. Ferrari closed at $197.18 at the end of the last trading period.
- According to Barclays, the prior rating for Pinduoduo Inc PDD was changed from Equal-Weight to Overweight. Pinduoduo earned $1.13 in the second quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $73.02 and a 52-week-low of $23.21. At the end of the last trading period, Pinduoduo closed at $53.09.
- According to Barclays, the prior rating for Annaly Capital Management Inc NLY was changed from Equal-Weight to Overweight. In the third quarter, Annaly Capital Management showed an EPS of $1.06, compared to $1.12 from the year-ago quarter. The current stock performance of Annaly Capital Management shows a 52-week-high of $32.72 and a 52-week-low of $15.11. Moreover, at the end of the last trading period, the closing price was at $17.84.
- For AGNC Investment Corp AGNC, Barclays upgraded the previous rating of Equal-Weight to Overweight. For the third quarter, AGNC Investment had an EPS of $0.84, compared to year-ago quarter EPS of $0.75. At the moment, the stock has a 52-week-high of $15.66 and a 52-week-low of $7.30. AGNC Investment closed at $7.92 at the end of the last trading period.
- Raymond James upgraded the previous rating for Renasant Corp RNST from Market Perform to Outperform. In the third quarter, Renasant showed an EPS of $0.79, compared to $0.71 from the year-ago quarter. The current stock performance of Renasant shows a 52-week-high of $40.79 and a 52-week-low of $27.61. Moreover, at the end of the last trading period, the closing price was at $35.58.
- According to Credit Suisse, the prior rating for Portland General Electric Co POR was changed from Underperform to Neutral. For the third quarter, Portland Gen Electric had an EPS of $0.65, compared to year-ago quarter EPS of $0.56. The stock has a 52-week-high of $57.03 and a 52-week-low of $41.58. At the end of the last trading period, Portland Gen Electric closed at $44.59.
See all analyst ratings upgrades.
Downgrades
- Jefferies downgraded the previous rating for ATI Physical Therapy Inc ATIP from Buy to Hold. In the second quarter, ATI Physical Therapy showed an EPS of $0.05, compared to $0.08 from the year-ago quarter. The current stock performance of ATI Physical Therapy shows a 52-week-high of $3.93 and a 52-week-low of $0.85. Moreover, at the end of the last trading period, the closing price was at $1.03.
- For FormFactor Inc FORM, Stifel downgraded the previous rating of Buy to Hold. FormFactor earned $0.24 in the third quarter, compared to $0.40 in the year-ago quarter. The current stock performance of FormFactor shows a 52-week-high of $47.48 and a 52-week-low of $24.26. Moreover, at the end of the last trading period, the closing price was at $27.14.
- BTIG downgraded the previous rating for Taylor Morrison Home Corp TMHC from Buy to Neutral. Taylor Morrison Home earned $2.72 in the third quarter, compared to $1.34 in the year-ago quarter. The current stock performance of Taylor Morrison Home shows a 52-week-high of $35.17 and a 52-week-low of $20.05. Moreover, at the end of the last trading period, the closing price was at $26.43.
- According to UBS, the prior rating for Seagate Technology Holdings PLC STX was changed from Buy to Neutral. For the first quarter, Seagate Tech Hldgs had an EPS of $0.48, compared to year-ago quarter EPS of $2.35. The current stock performance of Seagate Tech Hldgs shows a 52-week-high of $117.67 and a 52-week-low of $49.62. Moreover, at the end of the last trading period, the closing price was at $53.39.
- According to JP Morgan, the prior rating for VF Corp VFC was changed from Neutral to Underweight. In the second quarter, VF showed an EPS of $0.73, compared to $1.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $76.61 and a 52-week-low of $27.03. VF closed at $28.21 at the end of the last trading period.
- According to Credit Suisse, the prior rating for 1Life Healthcare Inc ONEM was changed from Outperform to Neutral. 1Life Healthcare earned $0.48 in the second quarter, compared to $0.30 in the year-ago quarter. The current stock performance of 1Life Healthcare shows a 52-week-high of $18.43 and a 52-week-low of $5.94. Moreover, at the end of the last trading period, the closing price was at $17.06.
- According to Credit Suisse, the prior rating for Cano Health Inc CANO was changed from Outperform to Neutral. In the second quarter, Cano Health showed an EPS of $0.03, compared to $0.03 from the year-ago quarter. The current stock performance of Cano Health shows a 52-week-high of $9.75 and a 52-week-low of $3.78. Moreover, at the end of the last trading period, the closing price was at $3.82.
- According to Morgan Stanley, the prior rating for Meta Platforms Inc META was changed from Overweight to Equal-Weight. For the third quarter, Meta Platforms had an EPS of $1.64, compared to year-ago quarter EPS of $3.22. The current stock performance of Meta Platforms shows a 52-week-high of $199.45 and a 52-week-low of $11.73. Moreover, at the end of the last trading period, the closing price was at $129.82.
- According to Cowen & Co., the prior rating for Meta Platforms Inc META was changed from Outperform to Market Perform. Meta Platforms earned $1.64 in the third quarter, compared to $3.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $199.45 and a 52-week-low of $11.73. Meta Platforms closed at $129.82 at the end of the last trading period.
- RBC Capital downgraded the previous rating for Masco Corp MAS from Outperform to Sector Perform. Masco earned $0.98 in the third quarter, compared to $0.99 in the year-ago quarter. The current stock performance of Masco shows a 52-week-high of $71.06 and a 52-week-low of $42.33. Moreover, at the end of the last trading period, the closing price was at $45.57.
- According to Raymond James, the prior rating for Amedisys Inc AMED was changed from Outperform to Market Perform. In the third quarter, Amedisys showed an EPS of $1.15, compared to $1.53 from the year-ago quarter. The current stock performance of Amedisys shows a 52-week-high of $179.91 and a 52-week-low of $91.15. Moreover, at the end of the last trading period, the closing price was at $105.34.
- B. Riley Securities downgraded the previous rating for Century Communities Inc CCS from Buy to Neutral. For the third quarter, Century Communities had an EPS of $4.44, compared to year-ago quarter EPS of $3.63. The stock has a 52-week-high of $82.49 and a 52-week-low of $39.00. At the end of the last trading period, Century Communities closed at $47.03.
- According to Needham, the prior rating for Silicon Laboratories Inc SLAB was changed from Buy to Hold. For the third quarter, Silicon Laboratories had an EPS of $1.21, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $211.98 and a 52-week-low of $113.47. At the end of the last trading period, Silicon Laboratories closed at $117.80.
- Keefe, Bruyette & Woods downgraded the previous rating for Evercore Inc EVR from Outperform to Market Perform. Evercore earned $2.20 in the third quarter, compared to $3.96 in the year-ago quarter. At the moment, the stock has a 52-week-high of $142.18 and a 52-week-low of $78.67. Evercore closed at $99.65 at the end of the last trading period.
- Goldman Sachs downgraded the previous rating for Arco Platform Ltd ARCE from Buy to Neutral. In the second quarter, Arco Platform showed an EPS of $0.08, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.74 and a 52-week-low of $9.90. Arco Platform closed at $11.26 at the end of the last trading period.
- According to Keybanc, the prior rating for Meta Platforms Inc META was changed from Overweight to Sector Weight. In the third quarter, Meta Platforms showed an EPS of $1.64, compared to $3.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $199.45 and a 52-week-low of $11.73. Meta Platforms closed at $129.82 at the end of the last trading period.
See all analyst ratings downgrades.
Initiations
- B. Riley Securities initiated coverage on 5E Advanced Materials Inc FEAM with a Buy rating. The price target for 5E Advanced Materials is set to $20.00. In the fourth quarter, 5E Advanced Materials showed an EPS of $0.30, compared to $0.15 from the year-ago quarter. The current stock performance of 5E Advanced Materials shows a 52-week-high of $49.50 and a 52-week-low of $9.02. Moreover, at the end of the last trading period, the closing price was at $12.22.
- With a Buy rating, Citigroup initiated coverage on IDEAYA Biosciences Inc IDYA. The price target seems to have been set at $26.00 for IDEAYA Biosciences. For the second quarter, IDEAYA Biosciences had an EPS of $0.57, compared to year-ago quarter EPS of $0.33. The stock has a 52-week-high of $24.09 and a 52-week-low of $8.14. At the end of the last trading period, IDEAYA Biosciences closed at $16.31.
- With an Outperform rating, Raymond James initiated coverage on Mercury Systems Inc MRCY. The price target seems to have been set at $55.00 for Mercury Sys. In the fourth quarter, Mercury Sys showed an EPS of $0.81, compared to $0.73 from the year-ago quarter. The stock has a 52-week-high of $72.28 and a 52-week-low of $40.48. At the end of the last trading period, Mercury Sys closed at $48.03.
- Needham initiated coverage on Arcellx Inc ACLX with a Buy rating. The price target for Arcellx is set to $31.00. In the second quarter, Arcellx showed an EPS of $0.88, compared to $36.42 from the year-ago quarter. The stock has a 52-week-high of $26.91 and a 52-week-low of $6.04. At the end of the last trading period, Arcellx closed at $20.27.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in